Handelsinvest Investeringsforvaltning’s Regeneron Pharmaceuticals REGN Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,854	Closed	-$1.53M	–	356
2023 Q3	$1.53M	Hold	1,854	–	–	0.53%	78
2023 Q2	$1.33M	Sell	1,854 -1,346	-42%	-$1.04M	0.26%	72
2023 Q1	$2.63M	Sell	3,200 -1,066	-25%	-$804K	0.42%	62
2022 Q4	$3.08M	Sell	4,266 -2,333	-35%	-$1.72M	0.49%	64
2022 Q3	$4.55M	Buy	6,599 +1,000	+18%	+$629K	0.71%	52
2022 Q2	$3.31M	Sell	5,599 -1,701	-23%	-$1.11M	0.49%	68
2022 Q1	$5.1M	Buy	7,300 +300	+4%	+$190K	0.62%	61
2021 Q4	$4.42M	Buy	7,000 +3,000	+75%	+$1.84M	0.45%	86
2021 Q3	$2.42M	Buy	+4,000	New	+$2.48M	0.26%	111

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's REGN Position: Q4 2023 in Review

Handelsinvest Investeringsforvaltning sold out of Regeneron Pharmaceuticals (REGN) in Q4 2023, closing a stake of 1,854 shares — an estimated $1.53M sold.

Handelsinvest Investeringsforvaltning first reported a position in REGN in Q3 2021 and held it in 9 quarters. The position peaked at $5.1M in Q1 2022. 1,273 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

Handelsinvest Investeringsforvaltning reported no remaining Regeneron Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Handelsinvest Investeringsforvaltning sold 1,854 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $1.53M.
Handelsinvest Investeringsforvaltning first reported a position in Regeneron Pharmaceuticals in Q3 2021 and held it in 9 quarters.
Handelsinvest Investeringsforvaltning's Regeneron Pharmaceuticals position peaked at $5.1M in Q1 2022.
1,273 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q4 2023, filed 11 Jan 2024.